Clinical Radiology
Volume 63, Issue 8 , Pages 843-852 , August 2008

Indeterminate lesions in cancer imaging

  • J.A. Spencer

      Affiliations

    • Corresponding Author InformationGuarantor and correspondent: John A. Spencer, Department of Clinical Radiology, St James's University Hospital, Beckett Street, Leeds LS7 9TF, UK. Tel.: +44 113 2064542; fax: +44 113 2065092.

Received 22 August 2007 ,Revised 9 November 2007 ,Accepted 25 November 2007.

References 

  1. Weg N, Scheer MR, Gabor MP. Liver lesions: improved detection with dual-detector-array CT and routine 2.5mm thin collimation. Radiology. 1998;209:417–426
  2. Jones EC, Chezmar JL, Nelson RC, et al. The frequency and significance of small (less than or equal to 15mm) hepatic lesions detected by CT. AJR Am J Roentgenol. 1992;158:535–539
  3. Yuan Y, Matsumoto T, Hiyama A, et al. The probability of malignancy in small pulmonary nodules coexisting with potentially operable lung cancer detected by CT. Eur Radiol. 2003;13:2447–2453
  4. Robinson PJ, Arnold P, Wilson D. Small “indeterminate” lesions on CT of the liver: a follow-up study of stability. Br J Radiol. 2003;76:866–874
  5. Robinson PJ. Imaging liver metastases: current limitations and future prospects. Br J Radiol. 2000;73:234–241
  6. Gollub MJ, Panicek DM, Bach AM, et al. Clinical importance of reinterpretation of body CT scans obtained elsewhere in patients referred for care at a tertiary cancer center. Radiology. 1999;210:109–112
  7. Tilleman EH, Phoa SS, Van Delden OM, et al. Reinterpretation of radiological imaging in patients referred to a tertiary referral centre with a suspected pancreatic or hepatobiliary malignancy: impact on treatment strategy. Eur Radiol. 2003;13:1095–1099
  8. Kalbhen CL, Yetter EM, Olson MC, et al. Assessing the resectability of pancreatic carcinoma: the value of reinterpreting abdominal CT performed at other institutions. AJR Am J Roentgenol. 1998;171:1571–1576
  9. Loughrey GJ, Carrington BM, Anderson H, et al. The value of specialist oncological radiology review of cross-sectional imaging. Clin Radiol. 1999;54:149–154
  10. Loevner LA, Sonners AI, Schulman BJ, et al. Reinterpretation of cross-sectional images in patients with head and neck cancer in the setting of a multidisciplinary cancer center. AJNR Am J Neuroradiol. 2002;23:1622–1626
  11. Wakeley CJ, Jones AM, Kabala JE, et al. Audit of the value of double reading magnetic resonance imaging films. Br J Radiol. 1995;68:358–360
  12. Robinson PJ. Radiology's Achilles' heel: error and variation in the interpretation of the Rontgen image. Br J Radiol. 1997;70:1085–1098
  13. Naik KS, Spencer JA, Craven CM, et al. Staging lymphoma with CT: comparison of contiguous and alternate 10mm slice techniques. Clin Radiol. 1998;53:523–527
  14. Caoili EM, Korobkin M, Francis IR, et al. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology. 2002;222:629–633
  15. Korobkin M, Francis IR. Imaging of adrenal masses. Urol Clin North Am. 1997;24:603–622
  16. Olawaiye A, Caesar L, Walsh D, et al. Analysis of the time interval between diagnoses in women with double primary breast and ovarian or primary peritoneal cancers. Gynecol Oncol. 2004;94:796–802
  17. Quint LE, Park CH, Iannettoni MD. Solitary pulmonary nodules in patients with extrapulmonary neoplasms. Radiology. 2000;217:257–261
  18. Kauff ND, Satagopan JM, Robson ME, et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2002;346:1609–1615
  19. Spencer JA, Swift SE, Wilkinson N, et al. Peritoneal carcinomatosis: image-guided peritoneal core biopsy for tumor type and patient care. Radiology. 2001;221:173–177
  20. Iizasa T, Suzuki M, Yoshida S, et al. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer. Ann Thorac Surg. 2006;82:254–260
  21. MacMahon H, Austin JH, Gamsu G, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology. 2005;237:395–400
  22. Spaepen K, Stroobants S, Dupont P, et al. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?. J Clin Oncol. 2001;19:414–419
  23. Israel O, Keidar Z, Bar-Shalom R. Positron emission tomography in the evaluation of lymphoma. Semin Nucl Med. 2004;34:166–179
  24. Margolis DJA, Hoffman JM, Herfkens RJ, et al. Molecular imaging techniques in body imaging. Radiology. 2007;245:333–356
  25. Hutchings M, Loft A, Hansen M, et al. FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Blood. 2006;107:52–59
  26. Spaepen K, Stroobants S, Dupont P, et al. Early restaging positron emission tomography with F-18 fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma. Ann Oncol. 2002;13:1356–1363
  27. Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25:522–529
  28. Metser U, Miller E, Lerman H, et al. Benign nonphysiologic lesions with increased 18F-FDG uptake on PET/CT: characterisation and incidence. AJR Am J Roentgenol. 2007;189:1203–1210
  29. Lardinois D, Weder W, Roudas M, et al. Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer. J Clin Oncol. 2005;23:6846–6853
  30. Kamel EM, Thumshirn M, Truninger K, et al. Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results. J Nucl Med. 2004;45:1804–1810
  31. Thoeni RF. Colorectal cancer. Radiologic staging. Radiol Clin North Am. 1997;35:457–485
  32. Torricelli P, Pecchi A, Luppi G, et al. Gadolinium-enhanced MRI with dynamic evaluation in diagnosing the local recurrence of rectal cancer. Abdom Imaging. 2003;28:19–27
  33. Even-Sapir E, Parag Y, Lerman H, et al. Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology. 2004;232:815–822
  34. Berger KL, Nicholson SA, Dehdashti F, et al. FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. AJR Am J Roentgenol. 2000;174:1005–1008
  35. The Royal College of Radiologists . Recommendations for cross-sectional imaging in cancer management: computed tomography—CT, magnetic resonance imaging—MRI, positron emission tomography CT-PET. London: The Royal College of Radiologists; 2006;

PII: S0009-9260(08)00051-2

doi: 10.1016/j.crad.2007.11.025

Clinical Radiology
Volume 63, Issue 8 , Pages 843-852 , August 2008